Bioscientists at Heidelberg University have studied the function of certain proteins, known as Argonaute (Ago) proteins, in the process of gene regulation. They sought to understand why only the Ago2 protein is able to target and directly turn off genes in humans, while the closely related Ago3 protein is not.
The puzzle symbolises the four principle domains from which human Argonaute proteins are built.
Pricture Credits: Dirk Grimm
Using a new investigative method, researchers working with Dr. Dirk Grimm were able to identify for the first time two "motifs" of this protein that, when properly combined with an already known protein domain, give Ago2 its gene-silencing capability. The researchers hope that the results will open up new avenues in basic biological and medical research toward artificially induced gene silencing.
With the aid of their special "directed protein evolution" method, the Heidelberg scientists were able to generate a large library of "hybrids" from human Ago2 and its close cousin Ago3. Individual proteins with the characteristics – the phenotype – of Ago2 were isolated from these chimaeras. A comparative bioinformatic analysis of the candidates with the strongest Ago2 phenotype yielded an "astonishing result", according to Dr. Grimm. The researchers from Heidelberg University's "CellNetworks" Cluster of Excellence observed a recurring accumulation of two short motifs in a special domain of the Argonaute protein, the N terminus at the end of the protein.
"This result was unexpected since the prevailing view holds that a completely different and known protein domain called the PIWI domain is solely responsible for the gene-regulating properties of Ago2," explains Dr. Grimm. "We were able to show, however, that only the correct combination of these three protein components gives Ago2 the ability to turn off genes in a special way." Gene silencing is based on what is known as RNA interference. Ago2, also called the slicer, slices the messenger RNA that transports the data stored in the DNA and translates it into proteins.
According to lead author Nina Schürmann, the results of this research provide new insight into Argonaute proteins. The results demonstrate that special Ago functions are not determined by isolated protein domains, but through the complex interaction of multiple activating or inhibiting domains. The researchers now hope that they will be able to generate completely new protein characteristics in future and, as a result, possibly even further improve RNA interference processes, according to Dr. Grimm. To advance the research further, the Heidelberg scientists generated a library of chimaeras of all four human Argonaute proteins as well as developed analysis software that can also benefit other users. In cooperation with Prof. Dr. Robert Russell and Dr. Leonardo Trabuco, likewise researchers in the "CellNetworks" Cluster of Excellence, a structure of human Ago3 could be modelled for the first time.
Dirk Grimm directs the CellNetworks "Virus-Host Interactions" Junior Research Group, which is located in the BioQuant Center of Heidelberg University. The group belongs to Heidelberg University Hospital‘s Department of Infectious Diseases under the direction of Prof. Dr. Hans-Georg Kräusslich and is supported by the Chica and Heinz Schaller Foundation (CHS). The results of the research were published in “Nature Structural & Molecular Biology”.
Marietta Fuhrmann-Koch | idw
Lethal combination: Drug cocktail turns off the juice to cancer cells
12.12.2018 | Universität Basel
Smelling the forest – not the trees
12.12.2018 | Universität Konstanz
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
13.12.2018 | Awards Funding
13.12.2018 | Earth Sciences
13.12.2018 | Materials Sciences